Institute of Genetic Medicine, European Academy of Bolzano/Bozen, Viale Druso/Drususallee 1, Bolzano/Bozen, Italy.
J Med Genet. 2011 Aug;48(8):549-56. doi: 10.1136/jmg.2010.088583. Epub 2011 Jun 20.
Thyroid hormones have important roles in growth, development and control of metabolism, and their dysregulation can lead to disease.
To identify genes contributing to hyperthyrotropinaemia.
DESIGN, SETTING, PARTICIPANTS: Linkage and association analyses using 1258 individuals from three Alpine villages.
The study applied two different upper limits of the reference range (URR) for serum thyroid stimulating hormone (TSH) values (TSH ≥4.6 mU/l and TSH >3.0 mU/l), along with normal or low fT4 (free thyroxine) values or thyroid medical treatment to define two groups of individuals for analysis: one hyperthyrotropinaemic or high-TSH (H-TSH) (TSH ≥4.6 mU/l) group; and a larger group (TSH >3.0 mU/l) called hyperthyrotropinaemic and upper reference range TSH (H+URR-TSH).
Non-parametric genome-wide linkage analysis was performed on pedigrees generated from the two groups. Linkage analysis in the H+URR-TSH group revealed a significant peak on chromosome 3q28-q29 (LOD 3.34) and a suggestive linkage peak on chromosome 6q26-27 (LOD 2.66). Analysis in the smaller hyperthyrotropinaemic (H-TSH) group supported linkage to chromosome 6q26-27. Single SNP and gene based SNP association analyses under the linkage peaks identified the PDE10A and DACT2 genes as candidates at the chromosome 6 locus.
PDE10A or DACT2 were identified as candidate genes contributing to hyperthyrotropinaemia (and possibly hypothyroidism) in this sample. Studies in additional populations support association of variants at this locus with TSH values, especially in the PDE10A gene. Genetic linkage in families with hyperthyrotropinaemia suggests the presence of functional variants that contribute to pathological disruption of the hypothalamus-pituitary-thyroid axis.
甲状腺激素在生长、发育和代谢控制中具有重要作用,其失调可导致疾病。
确定导致促甲状腺激素血症的基因。
设计、地点、参与者:使用来自三个阿尔卑斯山村的 1258 个人进行连锁和关联分析。
该研究应用了血清促甲状腺激素(TSH)值的两个不同参考范围上限(URR)(TSH≥4.6mU/l 和 TSH>3.0mU/l),以及正常或低游离甲状腺素(fT4)值或甲状腺药物治疗来定义两组供分析:一组促甲状腺激素血症或高 TSH(H-TSH)(TSH≥4.6mU/l);和一个较大的组(TSH>3.0mU/l),称为促甲状腺激素血症和上参考范围 TSH(H+URR-TSH)。
对来自这两组的家系进行了非参数全基因组连锁分析。在 H+URR-TSH 组中,连锁分析显示在 3q28-q29 染色体上有一个显著的峰(LOD 3.34),在 6q26-27 染色体上有一个提示性的连锁峰(LOD 2.66)。在较小的促甲状腺激素血症(H-TSH)组中,分析支持染色体 6q26-27 的连锁。在连锁峰下的单 SNP 和基于基因的 SNP 关联分析确定 PDE10A 和 DACT2 基因为 6 号染色体上的候选基因。
在该样本中,PDE10A 或 DACT2 被确定为导致促甲状腺激素血症(可能还有甲状腺功能减退症)的候选基因。在其他人群中的研究支持该基因座的变异与 TSH 值的关联,特别是在 PDE10A 基因中。促甲状腺激素血症家系的遗传连锁表明存在功能变异,导致下丘脑-垂体-甲状腺轴的病理性破坏。